Medtronic - 43 Year Stock Price History | MDT
- The all-time high Medtronic stock closing price was 124.38 on September 08, 2021.
- The Medtronic 52-week high stock price is 92.02, which is 15.4% above the current share price.
- The Medtronic 52-week low stock price is 68.84, which is 13.7% below the current share price.
- The average Medtronic stock price for the last 52 weeks is 82.64.
Medtronic Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 83.9864 | 82.1603 | 87.3673 | 79.0800 | 79.7400 | -2.40% |
2023 | 79.5823 | 75.0606 | 88.4126 | 68.2862 | 81.7041 | 9.61% |
2022 | 88.7169 | 98.7078 | 105.8340 | 72.3760 | 74.5427 | -22.55% |
2021 | 112.0769 | 105.6961 | 124.3780 | 92.0252 | 96.2424 | -9.81% |
2020 | 92.7699 | 101.9800 | 107.9798 | 64.9125 | 106.7165 | 5.67% |
2019 | 86.9695 | 76.6616 | 101.4754 | 71.8921 | 100.9919 | 27.33% |
2018 | 75.8229 | 70.5119 | 86.2689 | 65.6573 | 79.3124 | 14.51% |
2017 | 69.2571 | 59.5799 | 75.8012 | 59.5799 | 69.2597 | 15.23% |
2016 | 67.0882 | 62.6114 | 74.2135 | 60.0085 | 60.1031 | -5.44% |
2015 | 61.4547 | 58.2577 | 64.6077 | 53.0544 | 63.5617 | 8.62% |
2014 | 50.5707 | 45.5504 | 60.9938 | 42.6537 | 58.5171 | 28.13% |
2013 | 40.4441 | 32.6350 | 46.5963 | 32.6350 | 45.6697 | 42.87% |
2012 | 30.5714 | 29.2223 | 34.5959 | 27.4482 | 31.9648 | 10.64% |
2011 | 27.6595 | 27.5394 | 32.1803 | 22.7971 | 28.8899 | 5.81% |
2010 | 28.3536 | 31.6202 | 33.3043 | 22.8226 | 27.3038 | -13.81% |
2009 | 25.0484 | 23.0670 | 32.3404 | 17.2455 | 31.6778 | 42.53% |
2008 | 32.7991 | 34.4571 | 39.6081 | 20.1563 | 22.2253 | -36.33% |
2007 | 35.8585 | 36.2552 | 40.0869 | 31.4193 | 34.9050 | -5.22% |
2006 | 34.7035 | 39.4909 | 40.7116 | 29.1629 | 36.8264 | -6.29% |
2005 | 36.6706 | 33.5078 | 39.9278 | 33.1036 | 39.2997 | 16.72% |
2004 | 33.4655 | 32.6643 | 36.1177 | 31.3491 | 33.6705 | 2.68% |
2003 | 31.7888 | 31.3068 | 35.4112 | 28.9058 | 32.7925 | 7.23% |
2002 | 29.6791 | 33.3437 | 33.3437 | 22.5645 | 30.5825 | -10.35% |
2001 | 30.8349 | 39.4519 | 39.4519 | 25.9380 | 34.1114 | -14.80% |
2000 | 33.9599 | 22.6227 | 40.4465 | 22.6227 | 40.0354 | 66.33% |
1999 | 24.0199 | 24.0327 | 29.0161 | 20.6397 | 24.0693 | -1.49% |
1998 | 19.1096 | 16.3951 | 25.2268 | 14.9608 | 24.4340 | 42.11% |
1997 | 13.3600 | 10.9756 | 17.1943 | 9.5225 | 17.1943 | 55.23% |
1996 | 9.3610 | 8.4235 | 11.2200 | 7.6433 | 11.0766 | 22.37% |
1995 | 6.7692 | 4.3246 | 9.6999 | 4.2939 | 9.0520 | 101.79% |
1994 | 3.5755 | 3.2977 | 4.4858 | 2.8244 | 4.4858 | 36.94% |
1993 | 2.8553 | 3.7528 | 3.7528 | 2.1134 | 3.2758 | -13.04% |
1992 | 3.3162 | 3.6560 | 4.0933 | 2.5279 | 3.7670 | 1.94% |
1991 | 2.4510 | 1.6405 | 3.6953 | 1.5492 | 3.6953 | 119.72% |
1990 | 1.4613 | 1.2632 | 1.7842 | 1.1512 | 1.6818 | 32.90% |
1989 | 1.0067 | 0.7408 | 1.3475 | 0.7408 | 1.2655 | 71.38% |
1988 | 0.7778 | 0.8990 | 0.9367 | 0.6586 | 0.7384 | -15.77% |
1987 | 0.8454 | 0.7233 | 1.0136 | 0.6196 | 0.8766 | 21.78% |
1986 | 0.6684 | 0.4050 | 0.8521 | 0.4050 | 0.7198 | 76.72% |
1985 | 0.3199 | 0.2528 | 0.4120 | 0.2388 | 0.4073 | 61.12% |
1984 | 0.2828 | 0.4026 | 0.4073 | 0.2364 | 0.2528 | -34.95% |
1983 | 0.4577 | 0.5045 | 0.5548 | 0.3792 | 0.3886 | -22.61% |
1982 | 0.3932 | 0.3628 | 0.5244 | 0.3184 | 0.5021 | 39.71% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $105.230B | $31.227B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $185.422B | 24.34 |
Stryker (SYK) | United States | $128.275B | 31.81 |
Boston Scientific (BSX) | United States | $107.479B | 34.23 |
EssilorLuxottica (ESLOY) | France | $98.467B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $42.075B | 0.00 |
Haleon (HLN) | United Kingdom | $38.356B | 30.00 |
ResMed (RMD) | United States | $26.979B | 25.30 |
Terumo (TRUMY) | Japan | $24.775B | 34.99 |
Zimmer Biomet Holdings (ZBH) | United States | $24.604B | 15.84 |
Baxter (BAX) | United States | $20.430B | 14.90 |
Koninklijke Philips (PHG) | Netherlands | $19.242B | 15.35 |
Insulet (PODD) | United States | $11.496B | 60.36 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.440B | 0.00 |
Demant (WILYY) | Denmark | $9.943B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.860B | 23.42 |
BellRing Brands (BRBR) | United States | $7.238B | 38.92 |
Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
Haemonetics (HAE) | United States | $4.452B | 22.77 |
Perrigo (PRGO) | Ireland | $4.238B | 12.12 |
GN Store Nord (GNNDY) | Denmark | $3.889B | 25.18 |
Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.47 |
Envista Holdings (NVST) | United States | $3.441B | 13.09 |
QuidelOrtho (QDEL) | United States | $2.654B | 9.63 |
Neogen (NEOG) | United States | $2.591B | 24.92 |
Green Thumb Industries (GTBIF) | United States | $2.482B | 78.67 |
ICU Medical (ICUI) | United States | $2.303B | 17.19 |
TG Therapeutics (TGTX) | United States | $2.150B | 695.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.906B | 0.00 |
Owens & Minor (OMI) | United States | $1.848B | 17.74 |
Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.617B | 0.00 |
InMode (INMD) | Israel | $1.429B | 7.40 |
LeMaitre Vascular (LMAT) | United States | $1.414B | 46.66 |
National Vision Holdings (EYE) | United States | $1.399B | 43.58 |
AdaptHealth (AHCO) | United States | $1.273B | 9.58 |
Warby Parker (WRBY) | United States | $1.254B | 0.00 |
AtriCure (ATRC) | United States | $1.094B | 0.00 |
MacroGenics (MGNX) | United States | $0.899B | 0.00 |
Canopy Growth (CGC) | Canada | $0.872B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.764B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.686B | 14.82 |
Cresco Labs (CRLBF) | United States | $0.674B | 0.00 |
Evolus (EOLS) | United States | $0.664B | 0.00 |
Jin Medical (ZJYL) | China | $0.608B | 0.00 |
Quanterix (QTRX) | United States | $0.596B | 0.00 |
Valneva SE (VALN) | France | $0.526B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.504B | 10.91 |
PetIQ (PETQ) | United States | $0.480B | 17.93 |
TerrAscend (TSNDF) | Canada | $0.462B | 0.00 |
ZimVie (ZIMV) | United States | $0.421B | 25.80 |
Biote (BTMD) | United States | $0.416B | 3.96 |
OraSure Technologies (OSUR) | United States | $0.402B | 6.66 |
Surmodics (SRDX) | United States | $0.373B | 40.26 |
Aurora Cannabis (ACB) | Canada | $0.366B | 0.00 |
Zynex (ZYXI) | United States | $0.352B | 40.52 |
Viemed Healthcare (VMD) | United States | $0.310B | 30.81 |
Cerus (CERS) | United States | $0.308B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.266B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.238B | 14.73 |
Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.178B | 0.00 |
Omeros (OMER) | United States | $0.177B | 0.00 |
Veru (VERU) | United States | $0.177B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
High Tide (HITI) | Canada | $0.161B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.141B | 70.99 |
FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
InterCure (INCR) | Israel | $0.120B | 20.31 |
Fonar (FONR) | United States | $0.107B | 9.16 |
MariMed (MRMD) | United States | $0.100B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.097B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
Safety Shot (SHOT) | United States | $0.082B | 0.00 |
Brainsway (BWAY) | Israel | $0.080B | 0.00 |
Chimerix (CMRX) | United States | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.59 |
Apyx Medical (APYX) | United States | $0.051B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 14.95 |
Bright Green (BGXX) | United States | $0.035B | 0.00 |
Modular Medical (MODD) | United States | $0.033B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
Flora Growth (FLGC) | United States | $0.020B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 74.09 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |